Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Feb 2023 – 20 Aug 2026, limited by Tata Multicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Tata Multicap Fund | Nifty 500 |
|---|---|---|
| 09 Feb 2023 | ₹100.00 | ₹100.00 |
| 27 May 2023 | ₹104.07 | ₹104.44 |
| 12 Sep 2023 | ₹116.99 | ₹116.17 |
| 28 Dec 2023 | ₹126.88 | ₹129.07 |
| 13 Apr 2024 | ₹130.77 | ₹138.03 |
| 30 Jul 2024 | ₹150.07 | ₹155.96 |
| 14 Nov 2024 | ₹140.19 | ₹146.13 |
| 01 Mar 2025 | ₹119.60 | ₹132.27 |
| 17 Jun 2025 | ₹139.56 | ₹152.90 |
| 02 Oct 2025 | ₹140.94 | ₹152.55 |
| 17 Jan 2026 | ₹145.31 | ₹156.26 |
| 05 May 2026 | ₹146.53 | ₹151.75 |
| 20 Aug 2026 | ₹154.82 | ₹156.44 |
| Metric | Tata · Regular · IDCW NAV ₹15.57 Very High risk ★★☆☆☆ | Category median Multi Cap Fund · 28 funds |
|---|---|---|
| +8.79% | +4.94% | |
| +10.73% | +10.91% | |
| — | +10.25% | |
| — | +6.97% | |
| +13.20% | +12.72% | |
| +9.91% | — | |
| +12.24% | +14.29% | |
| — | +11.03% | |
| — | +5.66% | |
| Risk | ||
| 15.31% | 15.45% | |
| 0.28 | 0.28 | |
| 0.37 | 0.37 | |
| -22.86% | -22.16% | |
| Nifty 500 | — | |
| -1.01% | -0.86% | |
| 0.97 | 1.02 | |
| 92.0% | 101.7% | |
| 94.5% | 103.8% | |
| 2.14% | 2.17% | |
| ₹3,270Cr | ₹3,638Cr | |
| 0.50% | — | |
| None | — | |
| ₹150 | — | |
| ₹5.00K | — | |
| 51% | 53% | |
| Hasmukh Vishariya | — | |
| 09 Feb 2023 | — | |
| 79 | — | |
| 25.3% | — | |
| 3.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.